Mylan Total Assets 2006-2019 | MYL

Mylan total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Mylan total assets for the quarter ending June 30, 2019 were $31.817B, a 4.37% decline year-over-year.
  • Mylan total assets for 2018 were $32.735B, a 8.58% decline from 2017.
  • Mylan total assets for 2017 were $35.806B, a 3.11% increase from 2016.
  • Mylan total assets for 2016 were $34.726B, a 55.95% increase from 2015.
Mylan Annual Total Assets
(Millions of US $)
2018 $32,735
2017 $35,806
2016 $34,726
2015 $22,268
2014 $15,821
2013 $15,295
2012 $11,932
2011 $11,598
2010 $11,537
2009 $10,802
2008 $10,410
2007 $11,353
2007 $4,254
2006 $1,871
2005 $2,136
Mylan Quarterly Total Assets
(Millions of US $)
Q2 2019 $31,817
Q1 2019 $31,907
Q4 2018 $32,735
Q3 2018 $33,456
Q2 2018 $33,272
Q1 2018 $35,185
Q4 2017 $35,806
Q3 2017 $35,819
Q2 2017 $35,506
Q1 2017 $34,273
Q4 2016 $34,726
Q3 2016 $36,539
Q2 2016 $28,836
Q1 2016 $22,644
Q4 2015 $22,268
Q3 2015 $21,317
Q2 2015 $22,795
Q1 2015 $22,124
Q4 2014 $15,821
Q3 2014 $15,174
Q2 2014 $15,603
Q1 2014 $15,355
Q4 2013 $15,295
Q3 2013 $12,902
Q2 2013 $12,212
Q1 2013 $11,885
Q4 2012 $11,932
Q3 2012 $11,706
Q2 2012 $11,602
Q1 2012 $11,934
Q4 2011 $11,598
Q3 2011 $11,118
Q2 2011 $12,006
Q1 2011 $11,878
Q4 2010 $11,537
Q3 2010 $11,407
Q2 2010 $10,598
Q1 2010 $10,823
Q4 2009 $10,802
Q3 2009 $10,763
Q2 2009 $10,243
Q1 2009 $9,897
Q4 2008 $10,410
Q3 2008 $11,024
Q2 2008 $11,503
Q1 2008 $11,599
Q4 2007 $11,353
Q3 2007 $4,477
Q2 2007 $4,476
Q1 2007 $4,254
Q4 2006 $2,207
Q3 2006 $2,036
Q2 2006 $1,984
Q1 2006 $1,871
Q4 2005 $1,835
Q3 2005 $1,914
Q2 2005 $2,187
Q1 2005 $2,136
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $9.084B $11.434B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $51.285B 9.36
Bausch Health Cos (BHC) Canada $7.347B 4.90
Teva Pharmaceutical Industries (TEVA) Israel $6.726B 2.64
Dr Reddy's Laboratories (RDY) India $5.793B 19.49
ASPEN PHARMACR (APNHY) South Africa $2.008B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.417B 13.85
Amphastar Pharmaceuticals (AMPH) United States $0.987B 48.60
Voyager Therapeutics (VYGR) United States $0.762B 0.00
Homology Medicines (FIXX) United States $0.692B 0.00
CymaBay Therapeutics (CBAY) United States $0.403B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.344B 0.47
Akorn (AKRX) United States $0.322B 0.00
Assembly Biosciences (ASMB) United States $0.316B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.311B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.246B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.174B 0.00
Sol-Gel Technologies (SLGL) Israel $0.156B 0.00
Teligent (TLGT) United States $0.037B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00